Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

379 ARTÍCULOS , VIENDO DEL 316 AL 330

Vitamin E and memantine in Alzheimer's disease: clinical trial methods and baseline data

Dysken MW, Guarino PD, Vertrees JE, Asthana S, Sano M, Llorente M, Pallaki M, Love S, Schellenberg GD, McCarten JR, Malphurs J, Prieto S, Chen P, Loreck DJ, Carney S, Trapp G, Bakshi RS, Mintzer JE, Heidebrink JL, Vidal-Cardona A, Arroyo LM, Cruz AR, Kowall NW, Chopra MP, Craft S, Thielke S, Turvey CL, Woodman C, Monnell KA, Gordon K, Tomaska J, Vatassery G.

Alzheimers Dement. 2014 Jan;10(1):36-44. doi: 10.1016/j.jalz.2013.01.014. Epub 2013 Apr 11.

Alzheimer's disease: review of hormone therapy trials and implications for treatment and prevention after menopause

Henderson VW.

J Steroid Biochem Mol Biol. 2014 Jul;142:99-106. doi: 10.1016/j.jsbmb.2013.05.010. Epub 2013 May 28.

Targeting estrogen receptors for the treatment of Alzheimer's disease

Lee JH, Jiang Y, Han DH, Shin SK, Choi WH, Lee MJ.

Mol Neurobiol. 2014 Feb;49(1):39-49. doi: 10.1007/s12035-013-8484-9. Epub 2013 Jun 16.

Recent advances in the application of metabolomics to Alzheimer's Disease

Trushina E, Mielke MM.

Biochim Biophys Acta. 2014 Aug;1842(8):1232-9. doi: 10.1016/j.bbadis.2013.06.014. Epub 2013 Jun 29.

Targeting the mTOR signaling network for Alzheimer's disease therapy

Wang C, Yu JT, Miao D, Wu ZC, Tan MS, Tan L.

Mol Neurobiol. 2014 Feb;49(1):120-35. doi: 10.1007/s12035-013-8505-8. Epub 2013 Jul 14.

Therapeutic potential of turmeric in Alzheimer's disease: curcumin or curcuminoids?

Ahmed T, Gilani AH.

Phytother Res. 2014 Apr;28(4):517-25. doi: 10.1002/ptr.5030. Epub 2013 Jul 19.

Therapeutics of Alzheimer's disease: Past, present and future

Anand R, Gill KD, Mahdi AA.

Neuropharmacology. 2014 Jan;76 Pt A:27-50. doi: 10.1016/j.neuropharm.2013.07.004. Epub 2013 Jul 25.

How can we improve transfer of outcomes from randomized clinical trials to clinical practice with disease-modifying drugs in Alzheimer's disease?

Gauthier S, Leuzy A, Rosa-Neto P.

Neurodegener Dis. 2014;13(2-3):197-9. doi: 10.1159/000353748. Epub 2013 Aug 7.

Allopregnanolone as regenerative therapeutic for Alzheimer's disease: translational development and clinical promise

Irwin RW, Brinton RD.

Prog Neurobiol. 2014 Feb;113:40-55. doi: 10.1016/j.pneurobio.2013.08.004. Epub 2013 Sep 14.

Effect of donepezil in Alzheimer disease can be measured by a computerized human analog of the Morris water maze

Hort J, Andel R, Mokrisova I, Gazova I, Amlerova J, Valis M, Coulson EJ, Harrison J, Windisch M, Laczó J.

Neurodegener Dis. 2014;13(2-3):192-6. doi: 10.1159/000355517. Epub 2013 Oct 30.

Statins more than cholesterol lowering agents in Alzheimer disease: their pleiotropic functions as potential therapeutic targets

Barone E, Di Domenico F, Butterfield DA.

Biochem Pharmacol. 2014 Apr 15;88(4):605-16. doi: 10.1016/j.bcp.2013.10.030. Epub 2013 Nov 11.

Phase II crossover trial of varenicline in mild-to-moderate Alzheimer's disease

Kim SY, Choi SH, Rollema H, Schwam EM, McRae T, Dubrava S, Jacobsen J.

Dement Geriatr Cogn Disord. 2014;37(3-4):232-45. doi: 10.1159/000355373. Epub 2013 Nov 14.

Regenerative medicine in Alzheimer's disease

Felsenstein KM, Candelario KM, Steindler DA, Borchelt DR.

Transl Res. 2014 Apr;163(4):432-8. doi: 10.1016/j.trsl.2013.11.001. Epub 2013 Nov 8.

Changes of several brain receptor complexes in the cerebral cortex of patients with Alzheimer disease: probable new potential pharmaceutical targets

Falsafi SK, Roßner S, Ghafari M, Groessl M, Morawski M, Gerner C, Lubec G.

Amino Acids. 2014 Jan;46(1):223-33. doi: 10.1007/s00726-013-1623-9. Epub 2013 Nov 29.

Potential novel targets for Alzheimer pharmacotherapy: II. Update on secretase inhibitors and related approaches

Mikulca JA, Nguyen V, Gajdosik DA, Teklu SG, Giunta EA, Lessa EA, Tran CH, Terak EC, Raffa RB.

J Clin Pharm Ther. 2014 Feb;39(1):25-37. doi: 10.1111/jcpt.12112. Epub 2013 Dec 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias